Drugs / iDAP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06583291 | Oct 2024 → Oct 2028 expected | Parkinson disease | Anhui Provincial Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iDAP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06583291 ↗ |
| Modality | Cell therapy | “Allogeneic dopaminergic neural precursor cell(iDAP)” NCT06583291 ↗ |
| Route | Other | “MRI-guided bilateral stereotactic cell implantation” NCT06583291 ↗ |